查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
新城疫疫苗全球市場-2022-2029
市場調查報告書
商品編碼
1140685

新城疫疫苗全球市場-2022-2029

Global Newcastle Disease Vaccine Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

市場進入者對新疫苗的研發不斷增加，正在推動市場的增長。

推動市場增長的主要因素之一是動物公司推出的新動物疫苗的數量。此外，未來越來越多的管道產品進入將進一步促進市場的增長。例如，2022 年 5 月，基於新城疫病毒的三價疫苗對小鼠的 SARS-CoV-2 變體有效。本研究的結果表明，其三價製劑由祖先的武漢、Delta 和 Beta NDV-HXP-S 變體組成，對包括 Omicron 在內的系統發育較遠的 SARS-CoV-2 變體具有更高水平的抗病毒活性。被證明可以誘導交叉中和抗體。

此外，預測期內新興國家的增長也將推動市場的增長。由於對肉類的需求不斷增長，中國已成為畜牧業動物保健產品的最大市場之一。中國國家統計局數據顯示，2021年中國豬肉產量同比增長28.8%。 2021年中國肉類總產量為5296萬噸。此外，影響牲畜的疾病對動物生產力和肉類等食品具有破壞性影響。該倡議旨在通過提供預防這些疾病的途徑，減少非洲小農戶因新城疫、體內寄生蟲、東海岸熱和口蹄疫而遭受的年度損失。

地理滲透。

北美將是預測期內的主要地區。

在預測期內，北美市場以最大的市場份額引領全球新城疫疫苗市場。家禽相關食品消費量的增加、禽類疾病的高發病率、消費者對食品安全的看法等是推動該地區市場增長的因素，尤其是在美國。此外，家禽生產的繁榮對該地區的市場主導地位起著重要作用。根據聯合國糧食及農業組織（UNFAO）的數據，美國是世界上最大的雞肉生產國，2020年美國的雞總數為5.183億隻。此外，該國正在通過聯合戰略項目和收購推進家禽疫苗的引進，以進一步促進更好的家禽健康。

此外，預計亞太地區將在預測期內達到全球最高的複合年增長率。對家禽疫苗的認識不斷提高，加上該地區疫苗接種宣傳活動的增加，是預計在預測期內為市場提供增長機會的一些因素。

競爭格局。

新城疫疫苗市場由少數公司主導。市場增長的主要參與者包括 Boehringer Ingelheim、Seba Animal Health LLC、CAVAC、GALVmed、Hester Biosciences Limited、Merck Animal Health、Elanco、Zoetis, Inc 和 QYH Biotech。主要參與者將執行多項增長戰略，例如產品發布、收購和合作，據估計這些戰略將促進全球新城疫疫苗市場的增長。幾家主要的主要參與者已經在市場上推出了新的疫苗，以保護動物免受各種疾病的侵害。例如，2020年1月，勃林格殷格翰推出了一種名為VAXXITEK HVT+IBD+ND的疫苗，用於保護家禽免受馬立克氏病、傳染性法氏囊病（經典和變異）、新城疫等疾病的影響。該公司在其位於佐治亞州的生產基地生產這種疫苗，該基地每年生產超過 600 億劑家禽疫苗，供包括美國在內的 60 多個國家使用。 2022 年 6 月，Sebasante 收購了加拿大公司 Artemis Technologies, Inc.，以擴大其口服狂犬病疫苗產品組合。通過此次收購，Ceva 擴大了其在北美的業務。 2020 年 4 月，印度古瓦哈蒂理工學院和 Hester Biosciences 聯合開發了一種新的冠狀病毒疫苗（COVID-19）。該疫苗基於重組禽副粘病毒載體平台。

COVID-19 的影響將對全球新城疫疫苗市場產生負面影響。

COVID-19 的爆發無疑影響了全球新城疫疫苗市場。封鎖迫使獸醫關閉了他們的業務，即使在獸醫開放的情況下，公眾也害怕在他們開放的時候去他們那裡接種疫苗。因此，新城疫疫苗市場在 2020 年顯著下降。在 COVID-19 大流行之後，為防止疾病傳播而對動物疫苗接種的嚴格規定預計將在未來幾年推動市場增長。

內容

第 1 章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按類型劃分的市場細分
  • 按應用劃分的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
  • 促進因素
    • 全球肉類消費量增加
    • 新城疫疫苗新興市場
  • 抑制因素
    • 與疫苗相關的高成本
  • 機會
  • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST 分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 活疫苗
  • 滅活□□疫苗
  • 耐熱疫苗

第 8 章按應用程序

  • 雞
  • 火雞
  • 其他

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 競爭場景
  • 市場定位/市場份額分析
  • 併購分析

第 11 章公司簡介

  • Boehringer Ingelheim
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Ceva Animal Health LLC
  • CAVAC
  • GALVmed
  • Hester Biosciences Limited
  • Merck Animal Health
  • Elanco
  • QYH Biotech
  • Zoetis, Inc.
  • Merial
  • ChengDu Tecbond
  • Ringpu Biology
  • Qingdao Yebio Bioengineering Co. Ltd.
  • Other Companies

第 12 章 DataM

簡介目錄
Product Code: DMHCIT3001

Market Overview

Newcastle Disease Vaccine Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 3.6 % during the forecast period (2022-2029).

Newcastle disease is a contagious disease of birds that affects many avian species, both wild and domestic animals, and it is transmissible to humans. Several Newcastle disease vaccines available in the global market are appropriate for commercial chickens. The I-2 Newcastle disease vaccine, a thermostable vaccine, has been manufactured for local or regional development and tackles Newcastle disease in village chickens. After storage for 1-2 hours at room temperature, numerous Newcastle disease vaccinations deteriorate. It renders them unsuitable for use in villages where the vaccine must be transferred at room temperature for hours or days. Raising vaccines to limit outbreaks of avian disease and the increasing demand for food items related to poultry drive the global market's growth. The growing awareness drives the market among veterinary practitioners of animal vaccination, rising government food safety initiatives, and increasing meat consumption.

Market Dynamics: Rising R&D for the new vaccine by market players leads the market's growth.

One of the major factors augmenting the market's growth includes the number of new veterinary vaccines introduced by animal companies. Besides, increasing pipeline products that will enter the future further contribute to market growth. For instance, in May 2022, the Newcastle disease virus-based trivalent vaccine was effective across SARS-CoV-2 variants in mice. The present study findings demonstrated that its trivalent formulation, composed of the ancestral Wuhan, Delta, and Beta NDV-HXP-S variants, induced substantially high levels of cross-neutralizing antibodies against the phylogenetically distant SARS-CoV-2 variants, including Omicron.

Also, growth in emerging economies during the forecast period drives market growth. China's increasing demand for meat makes it one of the largest markets for animal healthcare products for livestock animals. According to the National Bureau of Statistics of China, pork production in China was up 28.8% year-on-year in 2021. China's total meat production is 52.96 million tons in the year 2021. Moreover, the diseases that affect livestock pose a devastating impact on animals' productivity and food products such as meat and other animal products. The initiative aims to reduce smallholder farmers' annual losses in Africa from Newcastle disease of poultry and endoparasites and East Coast fever and Foot-and-mouth disease by providing access to prevent such diseases.

Market Segmentation: Thermostable vaccine segment accounted for the highest share in global newcastle disease vaccine market.

The thermostable vaccine is expected to project the highest CAGR in the Newcastle disease vaccine market during the forecast period. This significant growth is due to its resistance to inactivation on exposure to high temperatures. Thermostable Newcastle disease virus (NDV) vaccines are used extensively to protect village chickens against Newcastle disease, backed by their decreased dependence on the cold chain for transport and storage. Though, the genetic basis underlying NDV thermostability is poorly understood.

By application, the newcastle disease vaccine market is classified into chicken, turkey, and others. A chicken segment held a significant role in the global Newcastle disease vaccine market during the forecast period. Chickens are susceptible to various infectious diseases. The viral disease known as Newcastle disease causes catastrophic losses to both village and commercial chickens and is among the most significant diseases that occur to chickens. Reducing large numbers of village chickens to Newcastle's contagious disease is a major first step in enhancing their productivity, driving the need for Newcastle disease vaccine chickens.

Geographical Penetration: North America is the dominating region during the forecast period.

The North American market leads with the largest market share in the global Newcastle disease vaccine market during the forecast period. Increased consumption of poultry-related food items, a high incidence of avian diseases, and consumer perception of food safety are some factors driving the market growth in the region, especially in the U.S. Moreover, poultry meat's thriving production has played a crucial role in the region's dominance in the market. According to the United Nations Food and Agriculture Organization (UNFAO), the U.S. is the largest producer of poultry meat globally; accounting For 2020, the number of all chickens in the United States totaled around 518.3 million. Furthermore, the country's adoption of poultry vaccines is being driven by joint strategic projects and acquisitions to foster better avian health further.

Moreover, the Asia Pacific region is expected to project the highest CAGR globally during the forecast period. The growing awareness of poultry vaccines coupled with the increase in the number of vaccination awareness programs in the region is some factors that are expected to offer growth opportunities to the market during the forecast period.

Competitive Landscape:

The Newcastle disease vaccine market is dominated by a few companies. Some of the key players in the market's growth include Boehringer Ingelheim, Ceva Animal Health LLC, CAVAC, GALVmed, Hester Biosciences Limited, Merck Animal Health, Elanco, Zoetis, Inc., and QYH Biotech, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the Newcastle disease vaccine market growth globally. Some major key players launched new vaccines in the market to protect animals from various diseases. For instance, in January 2020, Boehringer Ingelheim launched a vaccine named VAXXITEK HVT+IBD+ND to protect poultry from the diseases like Marek's Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease. The Company manufactured this vaccine at its manufacturing site in Georgia, which produced more than 60 billion doses of poultry vaccine a year for use in the United States and over 60 other countries. In June 2022, Ceva Sante acquired Canadian Firm Artemis Technologies, Inc. to expand its oral rabies vaccine portfolio. Through this acquisition, Ceva expands its presence in North America. In April 2020, the Indian Institute of Technology Guwahati and Hester Biosciences collaborated to develop a new vaccine against coronavirus (COVID-19). This vaccine is based on a recombinant avian paramyxovirus vector platform.

COVID-19 Impact: Negative impact on the global newcastle disease vaccine market.

The outbreak of COVID-19 has certainly impacted the global Newcastle disease vaccine market. The lockdown has compelled the veterinaries to close their operations, or even if the vets are open, the public was afraid to visit vets for vaccination in the meantime. Therefore, the Newcastle disease vaccine market significantly declined in 2020. Stringent regulations after the COVID-19 pandemic regarding the vaccinations of animals to prevent disease spread are expected to propel market growth in the next couple of years.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. The rise in consumption of meat globally
    • 4.2.2. Emerging markets of Newcastle Disease Vaccine
  • 4.3. Restraints:
    • 4.3.1. High cost associated with vaccines.
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Live Vaccines
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Killed Vaccines
    • 7.3.3. Thermostable Vaccines

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Chicken
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Turkey
    • 8.3.3. Others

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. The U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. The U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. The Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Boehringer Ingelheim*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Ceva Animal Health LLC
  • 11.3. CAVAC
  • 11.4. GALVmed
  • 11.5. Hester Biosciences Limited
  • 11.6. Merck Animal Health
  • 11.7. Elanco
  • 11.8. QYH Biotech
  • 11.9. Zoetis, Inc.
  • 11.10. Merial
  • 11.11. ChengDu Tecbond
  • 11.12. Ringpu Biology
  • 11.13. Qingdao Yebio Bioengineering Co. Ltd.
  • 11.14. Other Companies

12. DataM Intelligence

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us